Justin Denholm

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.

Giovanni Battista Migliori, Pei Min Thong, Onno Akkerman, Jan-Willem Alffenaar, Fernando Álvarez-Navascués, Mourtala Mohamed Assao-Neino, Pascale Valérie Bernard, Joshua Sorba Biala, François-Xavier Blanc, Elena M Bogorodskaya, Sergey Borisov, Danilo Buonsenso, Marianne Calnan, Paola Francesca Castellotti, Rosella Centis, Jeremiah Muhwa Chakaya, Jin-Gun Cho, Luigi Ruffo Codecasa, Lia D'Ambrosio, Justin Denholm, et al.

Journal article  |  2020  |  Emerging Infectious Diseases

Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in 16 countries on 5 continents showed that..

BCG vaccination: An update on current Australian practices

Jemma Wittner Taylor, Nigel Curtis, Justin Denholm

Journal article  |  2020  |  Australian Journal of General Practice

BACKGROUND: The Bacille Calmette-Guérin (BCG) vaccine is primarily used to prevent tuberculosis (TB) infection and disease in sett..

Perspectives of Vietnamese, Sudanese and South Sudanese immigrants on targeting migrant communities for latent tuberculosis screening and treatment in low-incidence settings: A report on two Victorian community panels

Chris Degeling, Stacy M Carter, Katie Dale, Kasha Singh, Krista Watts, Julie Hall, Justin Denholm

Journal article  |  2020  |  Health Expectations

BACKGROUND: Tuberculosis (TB) elimination strategies in Australia require a focus on groups who are at highest risk of TB infectio..

TB in stonemasons in Australia.

KM Cronin, MA Rees, EL Tay, RF Hoy, JT Denholm

Journal article  |  2020  |  The International Journal of Tuberculosis and Lung Disease

Responding to COVID-19: adjusting TB services in a low-burden setting.

K Watts, A McKeown, J Denholm, AM Baker

Journal article  |  2020  |  The International Journal of Tuberculosis and Lung Disease

A minimal common outcome measure set for COVID-19 clinical research.

undefined WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection

Journal article  |  2020  |  The Lancet Infectious Diseases

Clinical research is necessary for an effective response to an emerging infectious disease outbreak. However, research efforts are..

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial

Justin T Denholm, Joshua Davis, David Paterson, Jason Roberts, Susan Morpeth, Thomas Snelling, Dominica Zentner, Megan Rees, Matthew O'Sullivan, David Price, Asha Bowen, Steven YC Tong

Journal article  |  2020  |  Trials

OBJECTIVES: To determine if lopinavir/ritonavir +/- hydroxychloroquine will reduce the proportion of participants who survive with..

Clinical trials for the prevention and treatment ofCOVID-19: current state of play

Joshua S Davis, David Ferreira, Justin T Denholm, Steven YC Tong

Journal article  |  2020  |  Medical Journal of Australia

Since coronavirus disease 2019 (COVID-19) emerged in Wuhan, China in December 2019 and spread around the world, over 1100 clinical..

Estimating Long-term Tuberculosis Reactivation Rates in Australian Migrants

Katie D Dale, James M Trauer, Peter J Dodd, Rein MGJ Houben, Justin T Denholm

Journal article  |  2020  |  Clinical Infectious Diseases

BACKGROUND: The risk of progression to tuberculosis (TB) disease is greatest soon after infection, yet disease may occur many year..

Seasonality, climate change and tuberculosis: new data and old lessons.

J Denholm

Journal article  |  2020  |  The International Journal of Tuberculosis and Lung Disease